Effective October 1, 2015, the Board of Anavex Life Sciences Corp. has appointed Sandra Boenisch, to serve as the company's Principal Financial Officer until the earlier of a successor's appointment or her resignation. Ms. Boenisch is a Chartered Professional Accountant (CPA, CGA) with 14 years of accounting, audit, and financial reporting experience in a variety of industries, both in the United States and Canada.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.49 USD | +4.18% | +21.02% | -51.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.77% | 380M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.48% | 22.27B | |
-12.64% | 22.22B | |
-5.10% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- AVXL Stock
- News Anavex Life Sciences Corp.
- Anavex Life Sciences Corp. Appoints Sandra Boenisch to Serve as the Principal Financial Officer